Clinical trials: HLA Sensitization
HLA Sensitization
Desensitization in Kidney Transplantation
To determine if deletional strategies will provide effective desensitization.
- Trial name
- NCT00908583
- Testing
- plasmapheresis, Bortezomib, Rituximab
- Where
- 2 sites in United States
- Volunteers
- 44 people
- Sponsor
- University of Cincinnati
Kidney Failure, Chronic, Diabetic Nephropathies
Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.
This is a 12-month, phase II, prospective, open label study, to evaluate the effect of mycophenolate mofetil (MMF) among patients on the kidney transplant list with high Panel of Reactive Antibody (PRA) levels.
- Conditions
- Kidney Failure, Chronic, Diabetic Nephropathies, Glomerulonephritis, IGA, Hypertension, Renal
- Trial name
- NCT00446459
- Testing
- mycophenolate mofetil (CellCept)
- Where
- United States
- Volunteers
- 45 people
- Sponsor
- University of Washington